25 May 2013
Keywords: amylin, narrows, 3rd-qtr, loss, usa, pharmaceuticals, reported
Article | 15 November 2004
The USA's Amylin Pharmaceuticals has reported a 9% drop in third-quarter net loss to $34.1 million, or $0.36 per share, as a dip ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.